| HAS [Haute Autorité de Santé – French National Authority for Health] contribution. | 風濕性
> 軸性脊椎關節炎 | 監管合作關係
> 與監管機構合作 | 1,000 | National | Sometimes | 114996619378 |
| Patient contribution to the HAS [Haute Autorité de Santé – French National Authority for Health]. | 巨蟹座
> 癌症：血液 | 監管合作關係
> 與監管機構合作 | 100 | National | Sometimes | 114997550596 |
| Contributions during the evaluation of a new treatment. | 巨蟹座
> 癌症：罕見 | 監管合作關係
> 與監管機構合作 | 1,000 | National | Rarely | 115021537282 |
| Submissions to the HAS [Haute Autorité de Santé – French National Authority for Health] and exchanges with the ANSM [Agence nationale de sécurité du médicament et des produits de santé – National Agency for the Safety of Medicines and Health Products]. | 稀有
> 罕見疾病：呼吸系統 | 監管合作關係
> 與監管機構合作 | 1,000 | National | Regularly | 115037393435 |
| Engagement with HAS [Haute Autorité de Santé – French National Authority for Health]. | 巨蟹座
> 癌症：血液 | 監管合作關係
> 與監管機構合作 | 100,000 | National | Regularly | 115058165499 |
| ANSM [Agence nationale de sécurité du médicament et des produits de santé – National Agency for the Safety of Medicines and Health Products], the European Commission. | 稀有
> 罕見疾病：代謝/溶酶體 | 監管合作關係
> 與監管機構合作 | 5,000 | National | Sometimes | 119024758732 |
| Contributions submitted to the HAS [Haute Autorité de Santé – French National Authority for Health]. | 巨蟹座
> 癌症：血液 | 監管合作關係
> 參與健康技術評估（HTA）及給付審查 | 100,000 | National | Regularly | 114996624570 |
| ANSM [Agence nationale de sécurité du médicament et des produits de santé – National Agency for the Safety of Medicines and Health Products] sets the reimbursement rates for medicines. | 神經系統
> 神經系統：其他 | 監管合作關係
> 參與健康技術評估（HTA）及給付審查 | 1,000 | National | Sometimes | 114996998287 |
| HAS [Haute Autorité de Santé – French National Authority for Health] consultations. | 稀有
> 罕見疾病：大多數類型 | 監管合作關係
> 參與健康技術評估（HTA）及給付審查 | 1,000 | National | Sometimes | 114997498340 |
| ANSM [Agence nationale de sécurité du médicament et des produits de santé – National Agency for Medicines and Health Products Safety], HAS [Haute Autorité de Santé – French National Authority for Health]. | 神經退化性
> 帕金森氏症 | 監管合作關係
> 參與健康技術評估（HTA）及給付審查 | 100,000 | National | Sometimes | 115006691512 |
| HAS [Haute Autorité de Santé – French National Authority for Health] dossier submission for reimbursement. | 稀有
> 罕見疾病：遺傳性 | 監管合作關係
> 參與健康技術評估（HTA）及給付審查 | 100 | National | Sometimes | 115007035544 |
| Our national organisation is frequently consulted by the HAS [Haute Autorité de Santé – French National Authority for Health] and the CEPS [Comité Économique des Produits de Santé – Economic Committee for Health Products]. At the regional level, we contribute through concrete examples. | 稀有
> 罕見疾病：大多數類型 | 監管合作關係
> 參與健康技術評估（HTA）及給付審查 | 1,000 | Regional | Rarely | 115019695255 |
| HAS [Haute Autorité de Santé – French National Authority for Health]. | 巨蟹座
> 癌症：肺 | 監管合作關係
> 參與健康技術評估（HTA）及給付審查 | 100 | National | Sometimes | 115023193878 |
| HAS [Haute Autorité de Santé – French National Authority for Health]. | 風濕性
> 風濕性疾病：大多數類型 | 監管合作關係
> 參與健康技術評估（HTA）及給付審查 | 100,000 | National | Regularly | 115028340764 |
| Submissions to the HAS [Haute Autorité de Santé – French National Authority for Health] and exchanges with the ANSM [Agence nationale de sécurité du médicament et des produits de santé – National Agency for the Safety of Medicines and Health Products]. | 稀有
> 罕見疾病：呼吸系統 | 監管合作關係
> 參與健康技術評估（HTA）及給付審查 | 1,000 | National | Regularly | 115037393435 |
| HAS [Haute Autorité de Santé – French National Authority for Health], ANSM [Agence nationale de sécurité du médicament et des produits de santé – National Agency for the Safety of Medicines and Health Products], DGOS [Direction générale de l'offre de soins – Directorate General for Health Care Provision]. | 稀有
> 罕見疾病：貧血症 | 監管合作關係
> 參與健康技術評估（HTA）及給付審查 | 1,000 | National | Regularly | 115051867960 |
| Engagement with HAS [Haute Autorité de Santé – French National Authority for Health]. | 巨蟹座
> 癌症：血液 | 監管合作關係
> 參與健康技術評估（HTA）及給付審查 | 100,000 | National | Regularly | 115058165499 |
| HAS [Haute Autorité de Santé – French National Authority for Health], contributions to the AMM [autorisation de mise sur le marché – marketing authorisation] processes for new medicines. | 出血
> 出血性疾病：其他 | 監管合作關係
> 貢獻至行銷授權申請 | 1,000 | National | Regularly | 114998547552 |
| Opinions on new medicines prior to AMM [Autorisation de Mise sur le Marché – Marketing Authorisation]. | 病患安全
> 醫源性 | 監管合作關係
> 貢獻至行銷授權申請 | 1,000 | National | Regularly | 115006692431 |
| HAS [Haute Autorité de Santé – French National Authority for Health] contributions in support of AMM [Autorisation de Mise sur le Marché – Marketing Authorisation] applications. | 神經肌肉
> 重症肌無力 | 監管合作關係
> 貢獻至行銷授權申請 | Do not know | International | Regularly | 115019651354 |
| Apprenticeship programme at the ANSM [Agence nationale de sécurité du médicament et des produits de santé – National Agency for the Safety of Medicines and Health Products], contributing to the evaluation of medicinal products. | 內分泌
> 生長障礙 | 監管合作關係
> 貢獻至行銷授權申請 | 1,000 | International | Regularly | 115043122988 |
| Participation in fast-track designations for clinical trials, inclusion of adolescents, the Biotech Act, and related initiatives. | 巨蟹座
> 癌症：兒童／青少年 | 監管合作關係
> 貢獻至行銷授權申請 | 1,000 | International | Regularly | 115053274069 |
| ANSM [Agence nationale de sécurité du médicament et des produits de santé – National Agency for the Safety of Medicines and Health Products]. | 心血管
> 心血管：大多數類型 | 監管合作關係
> 貢獻至行銷授權申請 | 1,000 | National | Regularly | 115057828483 |
| Our national organisation is frequently consulted by the HAS [Haute Autorité de Santé – French National Authority for Health] and the CEPS [Comité Économique des Produits de Santé – Economic Committee for Health Products]. At the regional level, we contribute through concrete examples. | 稀有
> 罕見疾病：大多數類型 | 監管合作關係
> 出席/主持與政策制定者/監管機構的會議 | 1,000 | Regional | Rarely | 115019695255 |
| Consultation with the Ministry of Health. | 巨蟹座
> 癌症：乳癌 | 監管合作關係
> 出席/主持與政策制定者/監管機構的會議 | 10,000 | National | Rarely | 115037385316 |
| Apprenticeship programme at the ANSM [Agence nationale de sécurité du médicament et des produits de santé – National Agency for the Safety of Medicines and Health Products], contributing to the evaluation of medicinal products. | 內分泌
> 生長障礙 | 監管合作關係
> 出席/主持與政策制定者/監管機構的會議 | 1,000 | International | Regularly | 115043122988 |
| Engagement with members of parliament, the Ministry of Health, and the HAS [Haute Autorité de Santé – French National Authority for Health]; advocacy efforts to remove genomic tests from the RIHN [Référentiel des actes Innovants Hors Nomenclature – Reference Framework for Innovative Acts Outside the Nomenclature]; presentations at congresses and seminars; and chairing of symposia. | 巨蟹座
> 癌症：乳癌 | 監管合作關係
> 出席/主持與政策制定者/監管機構的會議 | 10,000 | National | Regularly | 115049335124 |
| Participation in fast-track designations for clinical trials, inclusion of adolescents, the Biotech Act [at EU level], and related initiatives. | 巨蟹座
> 癌症：兒童／青少年 | 影響政策與立法
> 影響醫療保健政策與法規 | 1,000 | International | Regularly | 115053274069 |
| Engagement with members of parliament, the Ministry of Health, and the HAS [Haute Autorité de Santé – French National Authority for Health]; advocacy efforts to remove genomic tests from the RIHN [Référentiel des actes Innovants Hors Nomenclature – Reference Framework for Innovative Acts Outside the Nomenclature]; presentations at congresses and seminars; and chairing of symposia. | 巨蟹座
> 癌症：乳癌 | 影響政策與立法
> 動員國會議員與政治領袖 | 10,000 | National | Regularly | 115049335124 |
| Regarding the reimbursement of growth hormone in 2012. | 稀有
> 罕見疾病：遺傳性 | 定價與可負擔性倡議
> 倡導公平的藥品定價 | 100 | National | Sometimes | 114999124203 |
| Legislation on patient out-of-pocket costs. | 巨蟹座
> 癌症：乳癌 | 定價與可負擔性倡議
> 倡導公平的藥品定價 | 1,000 | National | Regularly | 115028639358 |
| ANSM [Agence nationale de sécurité du médicament et des produits de santé – National Agency for the Safety of Medicines and Health Products] sets the reimbursement rates for medicines. | 神經系統
> 神經系統：其他 | 定價與可負擔性倡議
> 參與價格審查委員會談判 | 1,000 | National | Sometimes | 114996998287 |
| Legislation on patient out-of-pocket costs. | 巨蟹座
> 癌症：乳癌 | 定價與可負擔性倡議
> 解決低收入及弱勢族群的費用負擔問題 | 1,000 | National | Regularly | 115028639358 |
| Reimbursement of growth hormone. | 一般健康
> 一般健康 | 定價與可負擔性倡議
> 倡導將產品納入給付清單/國家藥品目錄 | 100 | National | Sometimes | 114996944911 |
| Regarding the reimbursement of growth hormone in 2012. | 稀有
> 罕見疾病：遺傳性 | 定價與可負擔性倡議
> 倡導將產品納入給付清單/國家藥品目錄 | 100 | National | Sometimes | 114999124203 |
| Advocacy efforts to remove genomic tests from the RIHN [Référentiel des actes Innovants Hors Nomenclature – Reference Framework for Innovative Acts Outside the Nomenclature] [The issue centers on genomic signature tests used in early-stage hormone receptor–positive, HER2-negative breast cancer, to determine whether adjuvant chemotherapy is likely to provide meaningful benefit. The logic is that this should allow many women to avoid unnecessary chemotherapy. However, the French breast-cancer patient groups argue that under the RIHN scheme elligible patients find it difficult to access the genomic tests. They want the genomic tests to be made available through the general social-security system.] | 巨蟹座
> 癌症：乳癌 | 定價與可負擔性倡議
> 倡導將產品納入給付清單/國家藥品目錄 | 10,000 | National | Regularly | 115049335124 |
| Correspondence submitted to request reimbursement of a specific voice prosthesis. | 身心障礙
> 殘疾：其他 | 改善存取路徑
> 促進藥品/醫療保健的公平取得 | 1,000 | National | Rarely | 115012114375 |
| Hybrid closed-loop systems, new CGM [Continuous Glucose Monitoring] devices. | 內分泌
> 糖尿病（1型和2型） | 改善存取路徑
> 促進藥品/醫療保健的公平取得 | 100 | Regional | Regularly | 115028487590 |
| The HAS [Haute Autorité de Santé – French National Authority for Health] should facilitate access to innovative medicines that hold a temporary authorisation. | 巨蟹座
> 癌症：血液 | 改善存取路徑
> 促進藥品/醫療保健的公平取得 | 1,000 | National | Regularly | 115051136978 |
| Patient advisory council for scientific studies. | 一般健康
> 肥胖症 | 以實證為基礎的病患意見
> 運用患者洞察來輔助決策 | 1,000 | International | Regularly | 115028400081 |
| Patient contributions to the HAS [Haute Autorité de Santé – French National Authority for Health]. | 巨蟹座
> 癌症：血液 | 以實證為基礎的病患意見
> 運用病患故事與親身經歷敘述 | 100 | National | Sometimes | 114997550596 |
| Our national organisation is frequently consulted by the HAS [Haute Autorité de Santé – French National Authority for Health] and the CEPS [Comité Économique des Produits de Santé – Economic Committee for Health Products]. At the regional level, we contribute through concrete examples. | 稀有
> 罕見疾病：大多數類型 | 以實證為基礎的病患意見
> 運用病患故事與親身經歷敘述 | 1,000 | Regional | Rarely | 115019695255 |
| Clinical trials, opinion videos. | 內分泌
> 糖尿病（1型和2型） | 以實證為基礎的病患意見
> 運用病患故事與親身經歷敘述 | 100,000 | National | Sometimes | 115049743006 |
| Patient rights and contributing our experience as patients. | 心血管
> 心血管：大多數類型 | 以實證為基礎的病患意見
> 運用病患故事與親身經歷敘述 | 100 | Regional | Regularly | 115060504774 |
| Questionnaire for input from patient and user associations. | 心血管
> 家族性高膽固醇血症（FH） | 以實證為基礎的病患意見
> 進行調查/研究以產生數據 | 1,000 | National | Sometimes | 115053041303 |
| Patient advisory council for scientific studies. | 一般健康
> 肥胖症 | 診斷與藥品配送
> 協作臨床試驗設計 | 1,000 | International | Regularly | 115028400081 |
| Clinical trials. | 內分泌
> 糖尿病（1型和2型） | 診斷與藥品配送
> 協作臨床試驗設計 | 100,000 | National | Sometimes | 115049743006 |
| Participation in fast-track designations for clinical trials, inclusion of adolescents, the Biotech Act, and related initiatives. | 巨蟹座
> 癌症：兒童／青少年 | 診斷與藥品配送
> 協作臨床試驗設計 | 1,000 | International | Regularly | 115053274069 |
| The Fédération Française des Groupements de Parkinsoniens [French Federation of Parkinson's Patient Groups] represents Parkinson's patients in health governance bodies and ministerial forums. | 神經退化性
> 帕金森氏症 | 機構治理
> 確保在政府諮詢機構中獲得代表性 | 1,000 | National | Regularly | 114997021296 |
| ANRS [Agence nationale de recherches sur le sida et les hépatites virales – National Agency for Research on AIDS and Viral Hepatitis], Coress [Coordination régionale en santé sexuelle - Regional Coordination for Sexual Health]. | HIV
> HIV 與肝炎 | 機構治理
> 在多方利害關係人網絡中有效運作 | 1,000 | National | Regularly | 115035724756 |
| Advocacy, discrimination. | 風濕性
> 乾癬與乾癬性關節炎 | 維護病患權益／提升生活品質
> 保護/改善病患體驗 | 100,000 | National | Regularly | 115042996062 |
| Patient rights and contributing our experience as patients. | 心血管
> 心血管：大多數類型 | 維護病患權益／提升生活品質
> 保護/改善病患體驗 | 100 | Regional | Regularly | 115060504774 |
互動
行動與倡議
27 提及
